150 related articles for article (PubMed ID: 7872722)
1. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.
Lai LC; Siraj AK; Erbas H; Lennard TW
Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
[TBL] [Abstract][Full Text] [Related]
3. Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid.
Erbas H; Lennard TW; Lai LC
Anticancer Res; 1999; 19(4B):3077-82. PubMed ID: 10652596
[TBL] [Abstract][Full Text] [Related]
4. Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid.
Lai LC; Siraj AK; Erbas H; Lennard TW
J Clin Endocrinol Metab; 1995 Feb; 80(2):711-4. PubMed ID: 7852541
[TBL] [Abstract][Full Text] [Related]
5. Oestradiol and epidermal growth factor in breast cyst fluid.
Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
[TBL] [Abstract][Full Text] [Related]
6. Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration.
Enriori PJ; Vázquez SM; Chiauzzi V; Pérez C; Fischer CR; Gori JR; Etkin AE; Charreau E; Calandra RS; Lüthy IA
Clin Endocrinol (Oxf); 2006 Jan; 64(1):20-8. PubMed ID: 16402924
[TBL] [Abstract][Full Text] [Related]
7. Breast cyst fluid plasmin activity and its effect on TGF-beta2 activation.
Erbas H; Erten O; Irfanoglu ME
Cancer Invest; 2008 Feb; 26(1):22-7. PubMed ID: 18181041
[TBL] [Abstract][Full Text] [Related]
8. Prostatic acid phosphatase in breast cyst fluid.
Erbas H; Erten O; Irfanoglu ME
Malays J Pathol; 2007 Dec; 29(2):95-9. PubMed ID: 19108401
[TBL] [Abstract][Full Text] [Related]
9. Melatonin and estrogen in breast cyst fluids.
Burch JB; Walling M; Rush A; Hennesey M; Craven W; Finlayson C; Anderson BO; Cosma G; Wells RL
Breast Cancer Res Treat; 2007 Jul; 103(3):331-41. PubMed ID: 17061046
[TBL] [Abstract][Full Text] [Related]
10. Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration.
Athanassiadou PP; Veneti SZ; Kyrkou KA; Intzes KS; Mouzaka LI; Papadimitriou GK
Cancer Detect Prev; 1992; 16(2):113-8. PubMed ID: 1600520
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibitory substances in human breast cyst fluid.
Lai LC; Chan CT; Cornell C; Lennard TW
Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217
[TBL] [Abstract][Full Text] [Related]
12. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.
Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F
Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108
[TBL] [Abstract][Full Text] [Related]
13. Electrolytes and trace elements in human breast cyst fluid.
Sişman AR; Sis B; Canda T; Onvural B
Biol Trace Elem Res; 2009 Apr; 128(1):18-30. PubMed ID: 18972071
[TBL] [Abstract][Full Text] [Related]
14. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.
Gann P; Chatterton R; Vogelsong K; Dupuis J; Ellman A
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):421-8. PubMed ID: 9184775
[TBL] [Abstract][Full Text] [Related]
16. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
18. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth factor-beta 1 and 2.
Lai LC; Erbas H; Meadows KA; Lennard TW; Holly JM
Cancer Lett; 1996 Dec; 110(1-2):207-12. PubMed ID: 9018103
[TBL] [Abstract][Full Text] [Related]
20. Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death.
Casey TM; Mulvey TM; Patnode TA; Dean A; Zakrzewska E; Plaut K
Exp Biol Med (Maywood); 2007 Sep; 232(8):1027-40. PubMed ID: 17720949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
